Israeli startup's personalised cell therapy gets FDA fast-track designation

Dec 22, 2024

Jerusalem [Israel], December 22 (ANI/TPS): Netanya-based biotechnology startup BioGenCell announced it has received the US Food and Drug Administration's Fast Track Designation for BGC101, a personalized cell therapy for severe Critical Limb Threatening Ischemia (CLTI).
CLTI is a life-threatening form of peripheral artery disease, usually occurring in the legs.
Using its TRACT platform, BGC101 regenerates damaged tissue, offering hope to patients with no other treatment options. The milestone follows promising clinical results. BioGenCell recently completed Phase 2 trial enrollment across the US, Europe, and Israel. (ANI/TPS)

More News

MEA Secretary CPV and OIA Arun Kumar Chatterjee (Photo/MEA YouTube)

PM Modi confident of India-GCC ties strengthening under Kuwait's Presidency: MEA

Dec 22, 2024

MEA Secretary CPV and OIA, Arun Kumar Chatterjee during a special briefing on the Prime Minister's visit to Kuwait said that in his meeting with Ahmad Al-Abdullah Al-Ahmad Al-Sabah, the Prime Minister of Kuwait, PM Modi engaged in delegation-level talks focused on deepening the strategic partnership between the two countries.

Russian president Vladimir Putin (Image source:TASS)

Russia never abandoned desire to normalise ties with US, says Putin

Dec 22, 2024

In an interview with Russian TV and radio outlet VGTRK Putin said, "It is possible to do everything if there is desire. We have never abandoned this desire."